Depression and the risk of coronary heart disease in the normative aging study

American Journal of Cardiology

Volumn 82, Issue 7, 1998, Pages 851-856

  Sesso, Howard D ^a   Kawachi, Ichiro ^b   Vokonas, Pantel S ^b   Sparrow, David ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; DEPRESSION; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SCORING SYSTEM;

AGING; COHORT STUDIES; COMORBIDITY; CORONARY DISEASE; DEPRESSION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MMPI; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 0032189349     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00491-3     Document Type: Article

References (30)

1. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91:999-1005.
2. Fielding R. Depression and acute myocardial infarction: a review and reinterpretation. Soc Sci Med 1991;32:1017-1028.
3. Carney RM, Freedland KE, Rich MW, Jaffe AS. Depression as a risk factor for cardiac events in established coronary heart disease - a review of possible mechanisms. Ann Behavioral Med 1995;17:142-149.
4. Carney RM, Rich MW, teVelde A, Saini J, Clark K, Freedland KE. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res 1988;32:159-164.
5. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 1995;76:562-564.
6. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA Follow-up. Circulation 1996;94:3123-3129.
7. Lapane KL, Zierler S, Lasater TM, Barbour MM, Carleton R, Hume AL. Is the use of psychotropic drugs associated with increased risk of ischemic heart disease? Epidemiology 1995;6:376-381.
8. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking: a national perspective. JAMA 1990;264:1541-1545.
9. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996;93:1976-1980.
10. Anda R, Williamson D, Jones D, Macera C, Eaker E, Glassman A, Marks J. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 1993;4:285-294.
11. Butcher JN, Dahlstrom WG, Graham JR, Tellegen A, Kaemmer B. MMPI-2: Minnesota Multiphasic Personality Inventory-2. Manual for administration and scoring. Minneapolis, MN: University of Minnesota Press, 1989.
12. Hathaway SR, McKinley JC. Minnesota Multiphasic Personality Inventory-2. Manual for Administration and Scoring. Minneapolis, MN: University of Minnesota Press, 1989.
13. Butcher JN, Graham JR, Williams CL, Ben-Porath YS. Development and Use of the MMPI-2 Content Scales. Minneapolis, MN: University of Minnesota Press, 1990.
14. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study, 18-year follow-up. Bethesda, MD: US DHEW, 1974 (DHEW publication no. 1693).
15. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. J Appl Psychol Meas 1977;1:385-401.
16. Ahern DK, Gorkin L, Anderson JL, Tierney C, Hallstrom A, Ewart C, Capone RJ, Schron E, Kornfeld D, Herd JA, et al. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 1990;66:59-62.
17. Murphy JM, Monson RR, Olivier DC, Sobol AM, Leighton AH. Affective disorders and mortality. A general population study. Arch Gen Psychiatry 1987; 44:473-480.
18. Wassertheil-Smoller S, Applegate WB, Berge K, Chang CJ, Davis BR, Grimm R Jr, Kostis J, Pressel S, Schron E. Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systolic Hypertension in the Elderly). Arch Intern Med 1996;156:553-561.
19. Vogt T, Pope C, Mullooly J, Hollis J. Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization. Am J Public Health 1994;84:227-231.
20. Brozek J, Keyes A, Blackburn H. Personality differences between potential coronary and noncoronary subjects. Ann N Y Acad Sci 1966;134:1057-1064.
21. Goldberg EL, Comstock GW, Hornstra RK. Depressed mood and subsequent physical illness. Am J Psychiatry 1979;136:530-534.
22. Ostfeld AM, Lebovits BZ, Shekelle RB, Paul O. A prospective study of the relationship between personality and coronary heart disease. J Chron Dis 1964;17:265-276.
23. van Doornen LJ. The coronary risk personality: psychological and psychophysiological aspects. Psychother Psychosom 1980;34:204-215.
24. Breslow MJ, Ligier B. Hyperadrenergic states. Crit Care Med 1991;19:1566-1579.
25. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. Heart rate variability from 24-hour electro cardiograph y and the 2-year risk for sudden death. Circulation 1993;88:180-185.
26. Winokur A, Maislin G, Phillips JL, Amsterdam JD. Insulin resistance after oral glucose tolerance testing in patients with major depression. Am J Psychiatry 1988;145:325-330.
27. Mueller PS, Davis JM, Bunney WE, Weil-Malherbe H, Cardon PV. Plasma free fatty acid concentration in depressive illness. Arch Gen Psychiatry 1970;22:217-221.
28. Wetzler S, Marlowe DB. The diagnosis and assessment of depression, mania, and psychosis by self-report. J Pers Assess 1993;60:1-31.
29. Ben-Porath YS, McCully E, Almagor M. Incremental validity of the MMPI-2 Content Scales in the assessment of personality and psychopathology by self-report. J Pers Assess 1993;61:557-575.
30. Thorogood M, Cowen P, Mann J, Murphy M, Vessey M. Fatal myocardial infarction and use of psychotropic drugs in young women. Lancet 1992;340:1067-1068.